SCHEMBL4837872

SCHEMBL4837872

Cc1cc(F)ccc1-c1ccc(S(=O)(=O)N2c3ccccc3C[C@H]2C(=O)O)cc1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 5/20 0.45
MMP3 P08254 3/20 0.45
LMNA P02545 2/20 0.45
MCL1 Q07820 3/20 0.43
POLB P06746 1/20 0.41
APOBEC3A P31941 1/20 0.41
APOBEC3G Q9HC16 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
BCL2L1 Q07817 1/20 0.40
BAK1 Q16611 1/20 0.40
TRIM24 O15164 1/20 0.40
PTGER3 P43115 1/20 0.39
ALDH1A1 P00352 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ESR1 P03372 1/20 0.38
PTGS2 P35354 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4841948 0.99 MMP8 (0.45) MMP8MMP3LMNAMCL1POLB
SCHEMBL4841938 0.91 LMNA (0.44) MMP8MMP3LMNAMCL1POLB
SCHEMBL4842575 0.90 MMP8 (0.47) MMP8MMP3LMNAMCL1POLB
SCHEMBL4837661 0.88 MAPT (0.44) MMP8MMP3LMNAMCL1POLB
SCHEMBL4834057 0.88 MMP8 (0.45) MMP8MMP3LMNAMCL1POLB
SCHEMBL4845158 0.86 MMP8 (0.58) MMP8MMP3LMNAMCL1POLB
SCHEMBL4843626 0.85 MCL1 (0.43) MMP8MMP3LMNAMCL1PTGER3
SCHEMBL4840572 0.83 LMNA (0.41) MMP8MMP3LMNA
SCHEMBL3820156 0.82 LMNA (0.43) LMNATDP1L3MBTL1PTGER3
SCHEMBL13986553 0.81 MCL1 (0.62) MMP8MMP3LMNAMCL1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 MMP8 3968/4885MMP3 3739/4885LMNA 1943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.